The world knows Martin Shkreli mostly for his controversial decision to crank up the price of an essential drug by 5,000 percent, earning him the moniker “Pharma Bro.” On Sunday, his Twitter account was suspended following a series of harassment Tweets directed at a female journalist.
The journalist in question is Lauren Duca and according to unnamed sources, she has been the subject of unwanted attention from Shkreli for several days, Boston Globe reports. The whole thing reportedly started after Duca’s appearance at a Fox News show hosted by Tucker Carlson where the two butted heads.
Before coming on, Duca had written a scathing article titled “Donald Trump is gaslighting America,” which was published in Teen Vogue. The Fox News host didn’t take kindly to how the president-elect was portrayed and made it known. After appearing on the show, Duca received numerous threats. Several days later, Shkreli started Tweeting the journalist with suggestive comments.
In one post, Shkreli asked Duca to be his plus-one during Trump’s inauguration, to which she responded by Tweeting “I would rather eat my own organs.” The pharmaceutical executive followed that up by posting photoshopped images of him and Duca, which the latter found inappropriate.
As a result of his actions, Twitter decided that it would be better for Shkreli to take some time off the micro-blogging service, confirming his suspension to the media via email. After the suspension, Duca made her own Tweet, wondering at how women immediately get harassed the moment they start getting attention for their work, Reuters reports.
"Why is harassment an automatic career hazard for a woman receiving any amount of professional attention?" Duca’s Tweet reads.
Considering what Shkreli is known to have done, which led to his dismissal as head of Turing Pharmaceuticals, this news might seem benign in comparison. However, it is indicative of a habit by “Pharma Bro” to not care about what anyone thought of his actions.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



